S 1418 Massachusetts Senate · 193rd Legislature (2023-2024)

An Act to restore integrity in the marketing of pharmaceutical products and medical devices

This bill amends Massachusetts state law to update definitions and regulations regarding the marketing of pharmaceutical products and medical devices. It directly affects pharmaceutical and medical device manufacturers, their marketing agents, and health care practitioners by clarifying what constitutes a "gift" and establishing stricter rules for reporting interactions between industry representatives and doctors. The legislation specifically defines terms like "gift" to exclude items of equal value exchanged under explicit contracts and clarifies who qualifies as a health care practitioner or marketer for reporting purposes. By replacing previous sections of Chapter 111N, the bill aims to ensure transparency in how these products are promoted within the state.
Bill status passed 3 of 4 stages cleared
Introduction
Feb 2023
Committee Review
Mar 2024
House Passage
Feb 2023
Governor
Introduced Feb 16, 2023 Last action Apr 22, 2024
Floor votes

How they voted

This bill passed the House. No roll call record of that vote is available.
Full legislative history

Actions timeline

Total actions
5
Key actions
2
Committee
2
Mar 21, 2024
Upper · Passed
Bill reported favorably by committee and referred to the committee on Health Care Financing
upper
Feb 16, 2023
Lower · Passed
House concurred
lower
Feb 16, 2023
Committee
Referred to the committee on Public Health
upper
1 primary · 0 co-sponsors

Sponsors